GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

Writing a TB lab procedure for critical results escalation

A TB laboratory procedure should turn a potentially urgent finding into a repeatable chain of decisions, authorised actions and documented communication. Writing a TB lab procedure for handling and reporting critical results with telephone escalation matters when smear microscopy, nucleic-acid testing, culture or antimicrobial susceptibility results may affect patient care and infection control.

The GLI Quality Tool’s four-phase roadmap and twelve Quality Systems Essentials provide a framework spanning laboratory safety, personnel, equipment, documentation, assessment and continual improvement. Adapt it for Australia, where public hospital pathology services, private providers such as Sonic Healthcare and regional laboratories share regulatory requirements but differ in staffing, contact routes and after-hours cover.

Define the result categories and scope

Start by defining which results are critical and who decides that status. A critical result should meet a locally approved rule: it is verified or strongly suspected, requires immediate clinical action and could cause serious harm if delayed. Depending on your test menu, candidates might include detection of Mycobacterium tuberculosis complex by a validated nucleic-acid amplification test, an unexpected positive acid-fast smear, or a validated culture finding that changes treatment or infection-control decisions. List only results supported by your diagnostic pathways, and label presumptive findings clearly.

Define out-of-specification results separately. These include failed controls, unsuitable specimens, instrument faults and findings outside validated reporting conditions; they require investigation rather than automatic release as confirmed results. The GLI Quality Tool provides practical advice on handling out-of-specification results. Specify when to hold a result, repeat testing, consult a microbiologist or reference laboratory, and communicate a preliminary finding without overstating its certainty. Cover all testing stages, departments and shifts, including provisional results.

Map the communication and escalation pathway

Map the pathway by result responsibility, not by the patient’s home address. A specimen collected in one state may be tested in another, and collection sites can forward work to a central laboratory. Name the primary recipient, such as the treating clinician or after-hours medical officer, then identify alternates for emergency departments, inpatient teams and community care. Include public-health or infection-prevention contacts where required, and maintain verified contact directories for each jurisdiction. Health services in New South Wales, Victoria and Queensland may use different escalation arrangements, so avoid relying on an assumed statewide number.

Decide what happens when the first recipient does not answer. Specify the number of attempts, intervals between attempts, whether a message may be left, the backup clinician and when the laboratory manager, on-call microbiologist or medical director becomes involved. A network with sites in Melbourne, Brisbane and Perth may use one after-hours roster, while a private operator may send specimens to a central laboratory elsewhere. Each pathway should identify the responsible laboratory and callback number, including weekends and public holidays.

Set telephone notification and escalation steps

Write the telephone sequence in plain, actionable language. Staff should identify themselves and their role, confirm the recipient’s identity, match two patient identifiers with the request, and state the test, result, collection date and reporting limit. Ask the recipient to read back the critical finding and agreed action. Record the date and time, number dialled, person reached, information given, read-back, action requested and responsible clinician. Use one stated time standard across states, and never send a result to an unverified personal number.

Protect confidentiality during the call. Australian privacy obligations, including the Privacy Act 1988 (Cth) and applicable state health-records legislation such as Victoria’s Health Records Act 2001, support verification and minimum-necessary disclosure. Do not disclose clinical details to an answering service or wrong number; leave only a callback request when policy allows. For an actual emergency, call 000 or 112 from a mobile and follow local emergency procedures, rather than using emergency services to deliver a laboratory result.

If the recipient disputes the result, document the concern and escalate to the result-authorising pathologist or on-call microbiologist. If an incorrect result has already been released, activate the nonconformity and incident process while the authorised team decides which clinicians and authorities require notification. Never leave an unacknowledged critical result with a receptionist or contractor without a defined handover.

Result situation Laboratory response Communication route Essential record
Critical TB finding Verify, assess validity and obtain authorisation Immediate telephone escalation to the treating or designated senior clinician Recipient, timestamp, read-back, agreed action and escalation
Out-of-specification result Hold, investigate and repeat or refer under the approved algorithm Contact the clinician when a preliminary finding changes immediate risk; involve the microbiologist Investigation, repeat result, impact review and release approval
Previously released affected result Open a nonconformity and assess related specimens and patient impact Notify affected clinicians and relevant authorities through the incident process Case record, impact assessment, notifications and corrective action

Build competence, safety and documentation controls

Treat competent communication as a measurable laboratory requirement. Specify training for smear interpretation, molecular-test interpretation, result authorisation, privacy, biosafety and escalation calls, with different depth for technical staff, authorised reporters and supervisors. Assess practical skills through observation or simulation, including an unanswered call, a disputed finding and an after-hours handover. Provide language support when needed and confirm patient identity using approved identifiers rather than relying on a relative’s account.

The TB biosafety training records resource offers a practical model for linking role-specific training, supervision and competency sign-off. Connect each record to induction, periodic reassessment and temporary or agency staff. Record assessment results, observed tasks, remedial action and authorisation to report independently. Link the procedure to equipment maintenance, reagent controls, safety risk assessments and controlled documents, then confirm that critical-value flags and telephone contacts in the laboratory information system match the approved list.

Control out-of-specification TB results

Apply a controlled investigation when a result is out of specification. Hold the report, preserve the specimen and relevant records, and determine whether the problem affects other specimens, controls or previously issued results. Repeat testing must follow a validated pathway and use suitable materials; a failed control does not convert a specimen into a positive test. Assess potential patient impact and involve the authorised pathologist before any release, referral or notification decision.

Communication must match the uncertainty. A preliminary finding that changes immediate clinical risk, such as an unexpected positive smear, may warrant prompt discussion with the treating team, infection prevention and the relevant TB program according to local rules. State that the finding is presumptive, explain what confirmation is pending and document the agreed follow-up. Investigate trends by instrument, reagent lot, operator and specimen type, then link corrective action to updated risk assessments, training, maintenance or the procedure itself.

Measure performance and support continual improvement

Measure the pathway rather than assuming it works. Use the assessment and continual-improvement stages of the GLI Quality Tool roadmap to audit critical-result notifications against relevant Quality Systems Essentials. Track time from result availability to notification, time to clinical acknowledgement, failed-call rates, unacknowledged results, out-of-specification investigation closure and staff competency. Compare shifts and sites, review cases that missed local targets, and retain evidence of corrective and preventive action.

Build review into the quality management system through management meetings and feedback from laboratory staff, after-hours colleagues, clinicians and infection prevention. Review near misses, wrong-number calls, delayed acknowledgements and changed contact details, then update the risk register, competency assessment and escalation list. A procedure review can follow a predefined cycle or be triggered by a significant event, a new test, a service change or updated guidance. Document who approved each change and how staff received it.

Turn the procedure into daily practice

Give the document an owner and an approval route. The laboratory manager can assign implementation responsibility, while the microbiologist, quality officer, clinical representative, infection-prevention lead and relevant TB program advise on content. Complete the local details: approved result categories, contact lists, response targets, backup pathways, documentation fields, training requirements and review dates. Confirm alignment with applicable ISO 15189 and National Association of Testing Authorities accreditation requirements. Pilot the procedure through a fictional after-hours scenario, then obtain authorisation before releasing version one.

Put the resource to work now: download the GLI Quality Tool checklists and user instructions for the relevant phase, adapt them to the procedure, and file the approved document in your quality management system. Issue the escalation record with the procedure, schedule competency assessment for each role and place the contact-directory check in the operational routine. Begin the first audit with the next critical result or simulated call, record the findings and schedule the first review in the laboratory quality meeting.